CLINICAL EVALUATION OF CEFMENOXIME IN THE INTERNAL MEDICINE, WITH SPECIAL REFERENCE TO INFECTION: ASSOCIATED WITH HEMATOLOGICAL DISORDERS
Clinical evaluation of cefmenoxime (CMX, Bestcall® ) was performed against infections associated with hematological, respiratory tract and other disorders. Clinical effectiveness of CMX against severe infectionswith hematological disorders including sepsis, pneumonia, pyelitis and so on was 74. 4% f...
Gespeichert in:
| Veröffentlicht in: | Japanese journal of antibiotics 1986/05/25, Vol.39(5), pp.1250-1258 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1258 |
|---|---|
| container_issue | 5 |
| container_start_page | 1250 |
| container_title | Japanese journal of antibiotics |
| container_volume | 39 |
| creator | KAWAMURA, SETSUKO SAKATA, YU CHIBA, YOICHI YOSHIDA, YUTAKA KANAZAWA, TETSUO KAWAZU, SHUNTARO TSUGE, MITSUO TANABE, KAZUHIKO NARA, HIDEYASU AIZAWA, MICHIRO KOMATSU, YOSHIHIKO YAMAGATA, AKIYOSHI SEGAWA, MASANOBU FUKUSI, KATSUHISA OKAMOTO, KATSUHIRO OHMI, TADANAO HIGUCHI, KENSHIRO SUGAWARA, YASUO AOYAMA, HITOSHI FUJIWARA, SHIRO TAKAMI, HIDEKI |
| description | Clinical evaluation of cefmenoxime (CMX, Bestcall® ) was performed against infections associated with hematological, respiratory tract and other disorders. Clinical effectiveness of CMX against severe infectionswith hematological disorders including sepsis, pneumonia, pyelitis and so on was 74. 4% for good responses and against the respiratory tract infections, 96. 2% for good responses was obtained. Neither objective or subjective side effects nor extreme abnormalities in laboratory tests were observed in these patients. It can be concluded, therefore, that CMX is one of the most useful drugs against infectious diseases associated with hematological disorders, respiratory tract and other disorders. |
| doi_str_mv | 10.11553/antibiotics1968b.39.1250 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_77065505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77065505</sourcerecordid><originalsourceid>FETCH-LOGICAL-j1215-72b4f3fd9fe1f5943555a5ca20f11c59c04fc459e4d89cda9167fea9f1cd84873</originalsourceid><addsrcrecordid>eNpdkU9Pg0AQxTdGU5vaj2CCF09SWZZh2WODi91IwVSq3nBZdhXTfwI9-O2FtOnBy7xk3i9vkjcI3WBngjEAuZebtiqqbVupBjM_KCaETbALzhkaujjwbfAoPUdDh_iB7dIAX6Jx01SFQzAN3C5igAbE8wmlMEQfYSwSEU5ji79O4-U0E2lipZEV8mjOk_RdzLklEiub9ZLxRdKRc_4gQpHwO-tNZDPr5ZmHolsveMQXPAm5laUdHPGwD7tCF0auGj0-6ggtI56FMztOH_u79jd2MdjULTxDTMmMxgaYRwBAgpKuYzBWwJTjGeUB014ZMFVKhn1qtGQGqzLwAkpG6PaQu6u3P3vdtPm6apRereRGb_dNTqnjAzjQgddHcF-sdZnv6mot69_8WEnnPx3876aVn_rky7orfKXz_-3nhOXQj_4FJ0p9yTrXG_IH9kV6Yg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77065505</pqid></control><display><type>article</type><title>CLINICAL EVALUATION OF CEFMENOXIME IN THE INTERNAL MEDICINE, WITH SPECIAL REFERENCE TO INFECTION: ASSOCIATED WITH HEMATOLOGICAL DISORDERS</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>KAWAMURA, SETSUKO ; SAKATA, YU ; CHIBA, YOICHI ; YOSHIDA, YUTAKA ; KANAZAWA, TETSUO ; KAWAZU, SHUNTARO ; TSUGE, MITSUO ; TANABE, KAZUHIKO ; NARA, HIDEYASU ; AIZAWA, MICHIRO ; KOMATSU, YOSHIHIKO ; YAMAGATA, AKIYOSHI ; SEGAWA, MASANOBU ; FUKUSI, KATSUHISA ; OKAMOTO, KATSUHIRO ; OHMI, TADANAO ; HIGUCHI, KENSHIRO ; SUGAWARA, YASUO ; AOYAMA, HITOSHI ; FUJIWARA, SHIRO ; TAKAMI, HIDEKI</creator><creatorcontrib>KAWAMURA, SETSUKO ; SAKATA, YU ; CHIBA, YOICHI ; YOSHIDA, YUTAKA ; KANAZAWA, TETSUO ; KAWAZU, SHUNTARO ; TSUGE, MITSUO ; TANABE, KAZUHIKO ; NARA, HIDEYASU ; AIZAWA, MICHIRO ; KOMATSU, YOSHIHIKO ; YAMAGATA, AKIYOSHI ; SEGAWA, MASANOBU ; FUKUSI, KATSUHISA ; OKAMOTO, KATSUHIRO ; OHMI, TADANAO ; HIGUCHI, KENSHIRO ; SUGAWARA, YASUO ; AOYAMA, HITOSHI ; FUJIWARA, SHIRO ; TAKAMI, HIDEKI</creatorcontrib><description>Clinical evaluation of cefmenoxime (CMX, Bestcall® ) was performed against infections associated with hematological, respiratory tract and other disorders. Clinical effectiveness of CMX against severe infectionswith hematological disorders including sepsis, pneumonia, pyelitis and so on was 74. 4% for good responses and against the respiratory tract infections, 96. 2% for good responses was obtained. Neither objective or subjective side effects nor extreme abnormalities in laboratory tests were observed in these patients. It can be concluded, therefore, that CMX is one of the most useful drugs against infectious diseases associated with hematological disorders, respiratory tract and other disorders.</description><identifier>ISSN: 0368-2781</identifier><identifier>EISSN: 2186-5477</identifier><identifier>DOI: 10.11553/antibiotics1968b.39.1250</identifier><identifier>PMID: 3463775</identifier><language>jpn</language><publisher>Japan: Japan Antibiotics Research Association</publisher><subject>Bacterial Infections - drug therapy ; Biliary Tract Diseases - drug therapy ; Cefmenoxime ; Cefotaxime - analogs & derivatives ; Cefotaxime - therapeutic use ; Hematologic Diseases - complications ; Humans ; Leukemia, Lymphoid - complications ; Leukemia, Myeloid, Acute - complications ; Neutropenia - drug therapy ; Pneumonia - drug therapy ; Respiratory Tract Infections - drug therapy ; Sepsis - drug therapy ; Urinary Tract Infections - drug therapy</subject><ispartof>The Japanese Journal of Antibiotics, 1986/05/25, Vol.39(5), pp.1250-1258</ispartof><rights>Japan Antibiotics Research Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3463775$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAWAMURA, SETSUKO</creatorcontrib><creatorcontrib>SAKATA, YU</creatorcontrib><creatorcontrib>CHIBA, YOICHI</creatorcontrib><creatorcontrib>YOSHIDA, YUTAKA</creatorcontrib><creatorcontrib>KANAZAWA, TETSUO</creatorcontrib><creatorcontrib>KAWAZU, SHUNTARO</creatorcontrib><creatorcontrib>TSUGE, MITSUO</creatorcontrib><creatorcontrib>TANABE, KAZUHIKO</creatorcontrib><creatorcontrib>NARA, HIDEYASU</creatorcontrib><creatorcontrib>AIZAWA, MICHIRO</creatorcontrib><creatorcontrib>KOMATSU, YOSHIHIKO</creatorcontrib><creatorcontrib>YAMAGATA, AKIYOSHI</creatorcontrib><creatorcontrib>SEGAWA, MASANOBU</creatorcontrib><creatorcontrib>FUKUSI, KATSUHISA</creatorcontrib><creatorcontrib>OKAMOTO, KATSUHIRO</creatorcontrib><creatorcontrib>OHMI, TADANAO</creatorcontrib><creatorcontrib>HIGUCHI, KENSHIRO</creatorcontrib><creatorcontrib>SUGAWARA, YASUO</creatorcontrib><creatorcontrib>AOYAMA, HITOSHI</creatorcontrib><creatorcontrib>FUJIWARA, SHIRO</creatorcontrib><creatorcontrib>TAKAMI, HIDEKI</creatorcontrib><title>CLINICAL EVALUATION OF CEFMENOXIME IN THE INTERNAL MEDICINE, WITH SPECIAL REFERENCE TO INFECTION: ASSOCIATED WITH HEMATOLOGICAL DISORDERS</title><title>Japanese journal of antibiotics</title><addtitle>Jpn. J. Antibiotics</addtitle><description>Clinical evaluation of cefmenoxime (CMX, Bestcall® ) was performed against infections associated with hematological, respiratory tract and other disorders. Clinical effectiveness of CMX against severe infectionswith hematological disorders including sepsis, pneumonia, pyelitis and so on was 74. 4% for good responses and against the respiratory tract infections, 96. 2% for good responses was obtained. Neither objective or subjective side effects nor extreme abnormalities in laboratory tests were observed in these patients. It can be concluded, therefore, that CMX is one of the most useful drugs against infectious diseases associated with hematological disorders, respiratory tract and other disorders.</description><subject>Bacterial Infections - drug therapy</subject><subject>Biliary Tract Diseases - drug therapy</subject><subject>Cefmenoxime</subject><subject>Cefotaxime - analogs & derivatives</subject><subject>Cefotaxime - therapeutic use</subject><subject>Hematologic Diseases - complications</subject><subject>Humans</subject><subject>Leukemia, Lymphoid - complications</subject><subject>Leukemia, Myeloid, Acute - complications</subject><subject>Neutropenia - drug therapy</subject><subject>Pneumonia - drug therapy</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Sepsis - drug therapy</subject><subject>Urinary Tract Infections - drug therapy</subject><issn>0368-2781</issn><issn>2186-5477</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU9Pg0AQxTdGU5vaj2CCF09SWZZh2WODi91IwVSq3nBZdhXTfwI9-O2FtOnBy7xk3i9vkjcI3WBngjEAuZebtiqqbVupBjM_KCaETbALzhkaujjwbfAoPUdDh_iB7dIAX6Jx01SFQzAN3C5igAbE8wmlMEQfYSwSEU5ji79O4-U0E2lipZEV8mjOk_RdzLklEiub9ZLxRdKRc_4gQpHwO-tNZDPr5ZmHolsveMQXPAm5laUdHPGwD7tCF0auGj0-6ggtI56FMztOH_u79jd2MdjULTxDTMmMxgaYRwBAgpKuYzBWwJTjGeUB014ZMFVKhn1qtGQGqzLwAkpG6PaQu6u3P3vdtPm6apRereRGb_dNTqnjAzjQgddHcF-sdZnv6mot69_8WEnnPx3876aVn_rky7orfKXz_-3nhOXQj_4FJ0p9yTrXG_IH9kV6Yg</recordid><startdate>198605</startdate><enddate>198605</enddate><creator>KAWAMURA, SETSUKO</creator><creator>SAKATA, YU</creator><creator>CHIBA, YOICHI</creator><creator>YOSHIDA, YUTAKA</creator><creator>KANAZAWA, TETSUO</creator><creator>KAWAZU, SHUNTARO</creator><creator>TSUGE, MITSUO</creator><creator>TANABE, KAZUHIKO</creator><creator>NARA, HIDEYASU</creator><creator>AIZAWA, MICHIRO</creator><creator>KOMATSU, YOSHIHIKO</creator><creator>YAMAGATA, AKIYOSHI</creator><creator>SEGAWA, MASANOBU</creator><creator>FUKUSI, KATSUHISA</creator><creator>OKAMOTO, KATSUHIRO</creator><creator>OHMI, TADANAO</creator><creator>HIGUCHI, KENSHIRO</creator><creator>SUGAWARA, YASUO</creator><creator>AOYAMA, HITOSHI</creator><creator>FUJIWARA, SHIRO</creator><creator>TAKAMI, HIDEKI</creator><general>Japan Antibiotics Research Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>198605</creationdate><title>CLINICAL EVALUATION OF CEFMENOXIME IN THE INTERNAL MEDICINE, WITH SPECIAL REFERENCE TO INFECTION</title><author>KAWAMURA, SETSUKO ; SAKATA, YU ; CHIBA, YOICHI ; YOSHIDA, YUTAKA ; KANAZAWA, TETSUO ; KAWAZU, SHUNTARO ; TSUGE, MITSUO ; TANABE, KAZUHIKO ; NARA, HIDEYASU ; AIZAWA, MICHIRO ; KOMATSU, YOSHIHIKO ; YAMAGATA, AKIYOSHI ; SEGAWA, MASANOBU ; FUKUSI, KATSUHISA ; OKAMOTO, KATSUHIRO ; OHMI, TADANAO ; HIGUCHI, KENSHIRO ; SUGAWARA, YASUO ; AOYAMA, HITOSHI ; FUJIWARA, SHIRO ; TAKAMI, HIDEKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j1215-72b4f3fd9fe1f5943555a5ca20f11c59c04fc459e4d89cda9167fea9f1cd84873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1986</creationdate><topic>Bacterial Infections - drug therapy</topic><topic>Biliary Tract Diseases - drug therapy</topic><topic>Cefmenoxime</topic><topic>Cefotaxime - analogs & derivatives</topic><topic>Cefotaxime - therapeutic use</topic><topic>Hematologic Diseases - complications</topic><topic>Humans</topic><topic>Leukemia, Lymphoid - complications</topic><topic>Leukemia, Myeloid, Acute - complications</topic><topic>Neutropenia - drug therapy</topic><topic>Pneumonia - drug therapy</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Sepsis - drug therapy</topic><topic>Urinary Tract Infections - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KAWAMURA, SETSUKO</creatorcontrib><creatorcontrib>SAKATA, YU</creatorcontrib><creatorcontrib>CHIBA, YOICHI</creatorcontrib><creatorcontrib>YOSHIDA, YUTAKA</creatorcontrib><creatorcontrib>KANAZAWA, TETSUO</creatorcontrib><creatorcontrib>KAWAZU, SHUNTARO</creatorcontrib><creatorcontrib>TSUGE, MITSUO</creatorcontrib><creatorcontrib>TANABE, KAZUHIKO</creatorcontrib><creatorcontrib>NARA, HIDEYASU</creatorcontrib><creatorcontrib>AIZAWA, MICHIRO</creatorcontrib><creatorcontrib>KOMATSU, YOSHIHIKO</creatorcontrib><creatorcontrib>YAMAGATA, AKIYOSHI</creatorcontrib><creatorcontrib>SEGAWA, MASANOBU</creatorcontrib><creatorcontrib>FUKUSI, KATSUHISA</creatorcontrib><creatorcontrib>OKAMOTO, KATSUHIRO</creatorcontrib><creatorcontrib>OHMI, TADANAO</creatorcontrib><creatorcontrib>HIGUCHI, KENSHIRO</creatorcontrib><creatorcontrib>SUGAWARA, YASUO</creatorcontrib><creatorcontrib>AOYAMA, HITOSHI</creatorcontrib><creatorcontrib>FUJIWARA, SHIRO</creatorcontrib><creatorcontrib>TAKAMI, HIDEKI</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese journal of antibiotics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAWAMURA, SETSUKO</au><au>SAKATA, YU</au><au>CHIBA, YOICHI</au><au>YOSHIDA, YUTAKA</au><au>KANAZAWA, TETSUO</au><au>KAWAZU, SHUNTARO</au><au>TSUGE, MITSUO</au><au>TANABE, KAZUHIKO</au><au>NARA, HIDEYASU</au><au>AIZAWA, MICHIRO</au><au>KOMATSU, YOSHIHIKO</au><au>YAMAGATA, AKIYOSHI</au><au>SEGAWA, MASANOBU</au><au>FUKUSI, KATSUHISA</au><au>OKAMOTO, KATSUHIRO</au><au>OHMI, TADANAO</au><au>HIGUCHI, KENSHIRO</au><au>SUGAWARA, YASUO</au><au>AOYAMA, HITOSHI</au><au>FUJIWARA, SHIRO</au><au>TAKAMI, HIDEKI</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CLINICAL EVALUATION OF CEFMENOXIME IN THE INTERNAL MEDICINE, WITH SPECIAL REFERENCE TO INFECTION: ASSOCIATED WITH HEMATOLOGICAL DISORDERS</atitle><jtitle>Japanese journal of antibiotics</jtitle><addtitle>Jpn. J. Antibiotics</addtitle><date>1986-05</date><risdate>1986</risdate><volume>39</volume><issue>5</issue><spage>1250</spage><epage>1258</epage><pages>1250-1258</pages><issn>0368-2781</issn><eissn>2186-5477</eissn><abstract>Clinical evaluation of cefmenoxime (CMX, Bestcall® ) was performed against infections associated with hematological, respiratory tract and other disorders. Clinical effectiveness of CMX against severe infectionswith hematological disorders including sepsis, pneumonia, pyelitis and so on was 74. 4% for good responses and against the respiratory tract infections, 96. 2% for good responses was obtained. Neither objective or subjective side effects nor extreme abnormalities in laboratory tests were observed in these patients. It can be concluded, therefore, that CMX is one of the most useful drugs against infectious diseases associated with hematological disorders, respiratory tract and other disorders.</abstract><cop>Japan</cop><pub>Japan Antibiotics Research Association</pub><pmid>3463775</pmid><doi>10.11553/antibiotics1968b.39.1250</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0368-2781 |
| ispartof | The Japanese Journal of Antibiotics, 1986/05/25, Vol.39(5), pp.1250-1258 |
| issn | 0368-2781 2186-5477 |
| language | jpn |
| recordid | cdi_proquest_miscellaneous_77065505 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Bacterial Infections - drug therapy Biliary Tract Diseases - drug therapy Cefmenoxime Cefotaxime - analogs & derivatives Cefotaxime - therapeutic use Hematologic Diseases - complications Humans Leukemia, Lymphoid - complications Leukemia, Myeloid, Acute - complications Neutropenia - drug therapy Pneumonia - drug therapy Respiratory Tract Infections - drug therapy Sepsis - drug therapy Urinary Tract Infections - drug therapy |
| title | CLINICAL EVALUATION OF CEFMENOXIME IN THE INTERNAL MEDICINE, WITH SPECIAL REFERENCE TO INFECTION: ASSOCIATED WITH HEMATOLOGICAL DISORDERS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A47%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CLINICAL%20EVALUATION%20OF%20CEFMENOXIME%20IN%20THE%20INTERNAL%20MEDICINE,%20WITH%20SPECIAL%20REFERENCE%20TO%20INFECTION:%20ASSOCIATED%20WITH%20HEMATOLOGICAL%20DISORDERS&rft.jtitle=Japanese%20journal%20of%20antibiotics&rft.au=KAWAMURA,%20SETSUKO&rft.date=1986-05&rft.volume=39&rft.issue=5&rft.spage=1250&rft.epage=1258&rft.pages=1250-1258&rft.issn=0368-2781&rft.eissn=2186-5477&rft_id=info:doi/10.11553/antibiotics1968b.39.1250&rft_dat=%3Cproquest_pubme%3E77065505%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77065505&rft_id=info:pmid/3463775&rfr_iscdi=true |